What is the percentage of thyroid cancer in the elderly population, particularly those over 65 years old?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Thyroid Cancer Prevalence in the Elderly

Thyroid cancer in elderly patients (≥65 years) represents a substantial and growing proportion of all thyroid cancer cases, with approximately 39-61% of papillary thyroid cancer cases now occurring in patients over age 45, and anaplastic thyroid carcinoma—the most aggressive form—predominantly affecting older patients with a mean diagnosis age of 71 years.

Age-Specific Incidence Patterns

The demographic shift in thyroid cancer has been dramatic over recent decades:

  • After 1999, the majority of papillary thyroid cancer cases shifted to patients older than 45 years, with 61% of cases occurring in this age group by 2006 1
  • By 2003,24% of all thyroid cancer cases were microcarcinomas (tumors <1 cm) specifically in patients over age 45 1
  • Anaplastic thyroid carcinoma, the most lethal subtype, predominantly affects elderly patients with a mean age at diagnosis of approximately 71 years, and fewer than 10% of cases occur in patients younger than 50 2

Mortality and Prognosis in Elderly Patients

The elderly population faces significantly worse outcomes:

  • Among thyroid cancer patients aged 60 years or older, 33.8% died after treatment in one cohort study, with 67.8% mortality specifically among those with non-well-differentiated thyroid carcinomas 3
  • Elderly patients (≥65 years) have significantly worse prognosis compared to younger age groups, with age being an independent prognostic factor 4
  • The American Joint Committee on Cancer recommends considering age as a continuous variable in predictive models, as there is no specific age cutoff that uniquely stratifies risk, though peak incidence occurs at age 50 2

Clinical Presentation Differences

Elderly patients present with distinct clinical characteristics:

  • Older patients more commonly present with larger tumors, advanced tumor grade, follicular subtypes, and advanced TNM stage at diagnosis 4
  • Delayed diagnosis is notable in aging patients compared to younger patients, with older patients presenting with subtle, non-specific symptoms that mimic aging or other systemic diseases 2, 3
  • Male elderly patients have higher proportions of advanced disease and worse prognosis than their female counterparts in differentiated tumors 4

Histologic Distribution in the Elderly

Among elderly thyroid cancer patients (≥60 years):

  • Well-differentiated thyroid carcinomas account for approximately 70% of cases (including papillary, follicular, and Hürthle cell carcinomas) 3
  • Non-well-differentiated thyroid carcinomas represent approximately 30% of cases in the elderly, including anaplastic thyroid carcinoma (the most common aggressive subtype), metastatic cancers, lymphomas, and squamous cell carcinomas 3
  • Papillary thyroid carcinoma remains the predominant histologic type across all age groups, accounting for approximately 80% of all thyroid cancers 5

Important Clinical Caveats

The increasing incidence of thyroid cancer in elderly patients is driven by increased detection of small papillary cancers, with 43% of tumors in patients older than 45 now measuring <1 cm 1. However, mortality from advanced-stage papillary thyroid cancer has increased 2.9% annually, indicating that not all of this increase represents overdiagnosis 6. Early diagnosis and aggressive treatment are particularly critical for elderly patients with non-well-differentiated thyroid cancers, given their substantially higher mortality rates 3.

References

Guideline

Age and Thyroid Cancer: Risk and Treatment Implications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Characteristics of thyroid carcinomas in aging patients.

European journal of clinical investigation, 2000

Guideline

Thyroid Cancer and Hypothyroidism Relationship

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.